Wall Street expectations for higher earnings and revenue in Avient (AVNT) for the June 2026 quarter have put the upcoming August 6 report in focus for investors assessing the stock’s recent performance.

At a share price of $36.32, Avient has given investors a 14.54% year to date share price return, while the 1 year total shareholder return of 10.93% and broadly flat 3 year total shareholder return suggest momentum has been modest and may be cooling slightly ahead of the August 6 earnings update.

If Avient’s setup has you reassessing your watchlist, this is also a good moment to widen the search and check out 18 top founder-led companies

After a steady climb in Avient’s share price this year and expectations already leaning positive into the August 6 update, the real puzzle now is whether most of the upside is already priced in or still ahead as valuation comes into focus.

Most Popular Narrative: 13.5% Undervalued

At a last close of $36.32, the most widely followed narrative for Avient points to a fair value of $42.00, which frames current pricing as leaving some room against that estimate.

Although growth vectors such as health care, defense and materials tied to artificial intelligence and data center buildout are gaining traction, they currently offset weakness in roughly 80% of the portfolio rather than driving broad-based expansion. This may keep overall revenue and EBITDA growth modest.

The fair value story for Avient hangs on a careful mix of gradual revenue growth, firmer margins and a future earnings multiple that assume solid but not spectacular progress. It raises the question of which specific growth and profitability assumptions sit underneath that $42.00 figure, and how much execution headroom the narrative builds in.

Result: Fair Value of $42.00 (UNDERVALUED)

However, Avient’s narrative could shift if growth in health care and defense accelerates within the portfolio, or if productivity gains lift margins more than currently assumed.

Next Steps

With mixed signals around Avient’s valuation and earnings potential, it makes sense to review the underlying data yourself and form a clear view. To see how the positives and concerns compare side by side, take a closer look at the 6 key rewards and 2 important warning signs

Looking for more investment ideas beyond Avient?

If Avient is already on your radar, do not stop there. Put a few more quality ideas on your watchlist so you are not relying on a single story.

• Start broadening your opportunity set with companies that combine quality and value by checking out 55 high quality undervalued stocks.
• Strengthen the income side of your portfolio by reviewing businesses featured in the 9 dividend fortresses.
• Reduce potential downside by focusing on companies highlighted in the 81 resilient stocks with low risk scores.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.